WASHINGTON \u00a0\u2014\u00a0The White House\u2019s TrumpRx website went live Thursday with a promise to instantly deliver prescription drugs at \u201cthe lowest price anywhere in the world.\u201d <\/p>\n
\u201cThis launch represents the largest reduction in prescription drug prices in history by many, many times, and it\u2019s not even close,\u201d President Trump said at a news conference announcing the launch of the platform. <\/p>\n
Drug policy experts say the jury is still out on whether the platform will provide the significant savings Trump promises, though it will probably help people who need drugs not commonly covered by insurance. <\/p>\n
Senate Democrats, meanwhile, called the site a \u201cvanity project\u201d and questioned whether the program presents a possible conflict of interest involving the pharmaceutical industry and the Trump family.<\/p>\n
What is TrumpRx, really?<\/p>\n
The new platform, trumprx.gov<\/a>, is designed to help uninsured Americans find discounted prices for high-cost, brand-name prescriptions, including fertility, obesity and diabetes treatments. <\/p>\n The site does not directly sell drugs. Instead, consumers browse a list of discounted medicines, and select one for purchase. From there, they either receive a coupon accepted at certain pharmacies or are routed directly to a drug manufacturer\u2019s website to purchase the prescription.<\/p>\n The White House said the reduced prices are possible after the administration negotiated voluntary \u201cmost favored nation\u201d agreements with 16 major drugmakers including Pfizer, Eli Lilly and Novo Nordisk.<\/p>\n Under these deals, manufacturers have agreed to set certain U.S. drug prices no higher than those paid in other wealthy nations in exchange for three-year tariff exemptions. However, the full legal and financial details of the deals have not been made public, leaving lawmakers to speculate how TrumpRx\u2019s pricing model works.<\/p>\n What does it accomplish?<\/p>\n Though the White House has framed TrumpRx as a historic reset for prescription drug costs, economists said the platform offers limited new savings.<\/p>\n But it does move the needle on the issue of drug pricing transparency, away from the hidden mechanisms behind how prescription drugs are priced, rebated and distributed, according to Geoffrey Joyce, director of health policy at the USC Schaeffer Center for Health Policy and Economics. <\/p>\n \u201cThis has been a murky world, a terrible, obscure, opaque marketplace where drug prices have been inconsistently priced to different consumers,\u201d Joyce said, \u201cSo this is a little step in the right direction, but it\u2019s mostly performative from my perspective, which is kind of Trump in a nutshell.\u201d<\/p>\n Still, for the uninsured or people seeking \u201clifestyle drugs\u201d \u2014 like those for fertility or weight loss that insurers have historically declined to cover \u2014 TrumpRx could become a useful option, Joyce said. <\/p>\n \u201cIt\u2019s kind of a win for Trump and a win for Pfizer,\u201d Joyce said. \u201cThey get to say, \u2018Look what we\u2019re doing. We\u2019re lowering prices. We\u2019re keeping Trump happy, but it\u2019s on our low-volume drugs, and drugs that we were discounting big time anyway.\u2019\u201d <\/p>\n Where does it fall short?<\/p>\n Early analyses by drug policy experts suggest many of the discounted medications listed on the TrumpRx site were already on offer through other drug databases before the platform launched. <\/p>\n For example, Pfizer\u2019s Duavee menopause treatment is listed at $30.30 on TrumpRx, but it is also available for the same price at some pharmacies via GoodRx. <\/p>\n Weight management drug Wegovy starts at $199 on TrumpRx. Manufacturers were already selling the same discounted rates through its NovoCare Pharmacy program before the portal\u2019s launch. <\/p>\n \u201c[TrumpRx] uses data from GoodRx, an existing price-search database for prescription drugs,\u201d said Darius N. Lakdawalla, a senior health policy researcher at USC. \u201cIt seems to provide prices that are essentially the same as the lowest price GoodRx reports on its website.\u201d<\/p>\n Compared to GoodRx, TrumpRx covers a modest subset of drugs: 43 in all.<\/p>\n \u201cUninsured consumers, who do not use or know about GoodRx and need one of the specific drugs covered by the site, might benefit from TrumpRx. That seems like a very specific set of people,\u201d Lakdawalla said.<\/p>\n Where do Democrats stand?<\/p>\n Democrats slammed the program this week, saying it would not provide substantial discounts for patients, and called for greater transparency around the administration\u2019s dealings with drugmakers. To date, the administration has not disclosed the terms of the pricing agreements with manufacturers such as Pfizer and AstraZeneca.<\/p>\n In the lead-up to the TrumpRx launch, Democratic members of Congress questioned its usefulness and urged federal health regulators to delay its debut.<\/p>\n \u201cThis is just another Donald Trump pet project to rebrand something that already exists, take credit for it, and do nothing to actually lower healthcare prices,\u201d Sen. Alex Padilla (D-Calif.) said Friday. \u201cDemocrats will continue fighting to lower healthcare costs and push Republicans to stop giving handouts to billionaires at the expense of working-class Americans.\u201d <\/p>\n Three other Democratic senators \u2014 Dick Durbin, Elizabeth Warren and Peter Welch \u2014 raised another concern in a Jan. 29 letter<\/a> to Thomas March Bell, inspector general for the Department of Health and Human Services. <\/p>\n The three senators pointed to potential conflicts of interest between TrumpRx and an online dispensing company, BlinkRx. <\/p>\n